Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations
Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations
复制标题
DOI：
10.1186/s12943-019-1062-7
复制
发表时间：
2019
期刊：
影响因子：
37.3
通讯作者：
Zhang Jian
中科院分区：
文献类型：
--
作者：
Lin Anqi;Wei Ting;Meng Hui;Luo Peng;Zhang Jian
